Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Flavia Salvi"'
Autor:
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, Bernardino Allione, Emanuele Angelucci, Marco Bruzzone, Tullio Calzamiglia, Marina Cavaliere, Maurizio Cavalleri, Daniela Cilloni, Marino Clavio, Elena Crisà, Anna Da Col, Paolo Danise, Federica Pilo, Dario Ferrero, Carlo Finelli, Daniela Gioia, Roberto Massimo Lemoli, Elisa Masiera, Emanuela Messa, Maurizio Miglino, Pellegrino Musto, Esther Natalie Oliva, Antonella Poloni, Flavia Salvi, Alessandro Sanna, Marco Scudeletti, Rodolfo Tassara, Valeria Santini
Publikováno v:
Cancer Medicine, Vol 8, Iss 18, Pp 7567-7576 (2019)
Abstract Background Erythropoiesis‐stimulating agents effectively improve the hemoglobin levels in a fraction of anemic patients with myelodysplastic syndromes (MDS). Higher doses (HD) of recombinant human erythropoietin (rhEPO) have been proposed
Externí odkaz:
https://doaj.org/article/138e7105345a42ddac1dc39908b0c2b5
Autor:
Emanuela Messa, Daniela Gioia, Elisa Masiera, Anna Castiglione, Manuela Ceccarelli, Flavia Salvi, Paolo Danise, Alessandro Sanna, Bernardino Allione, Enrico Balleari, Antonella Poloni, Giovanni Cametti, Dario Ferrero, Rodolfo Tassara, Carlo Finelli, Margherita Bonferroni, Pellegrino Musto, Giuseppe Saglio, Alessandro Levis, Valeria Santini
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/49fd98bf53e04381b570812f4522d35e
Autor:
Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Federico Monaco, Debora Degl’Innocenti, Flavia Salvi, Umberto Vitolo, Lisa Argnani, Paolo Corradini, Pier Luigi Zinzani, On behalf of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi Onlus, FIL)
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-7 (2016)
Abstract Background There is no consensus regarding optimal treatment for peripheral T-cell lymphomas (PTCL), especially in relapsed or refractory cases, which have very poor prognosis and a dismal outcome, with 5-year overall survival of 30 %. Metho
Externí odkaz:
https://doaj.org/article/7f63a7964ca947f0bb87ef0dba8b2cf2
Autor:
Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were prospectively defined as frail using a simplified version of the Compr
Externí odkaz:
https://doaj.org/article/113d9dc70ef24344a9ccaa66f023382d
Autor:
Francesco Zaja, Simone Ferrero, Caterina Stelitano, Angela Ferrari, Flavia Salvi, Annalisa Arcari, Gerardo Musuraca, Barbara Botto, Michele Spina, Claudia Cellini, Caterina Patti, Anna M. Liberati, Claudia Minotto, Stefano A. Pileri, Manuela Ceccarelli, Stefano Volpetti, Antonella Ferranti, Daniela Drandi, Elisa Montechiarello, Marco Ladetto, James Carmichael, Renato Fanin
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
Externí odkaz:
https://doaj.org/article/7bdbd6430ba642b6871d8eaf5f306fc8
Autor:
Gioacchino Catania, Francesco Zallio, Federico Monaco, Maria Teresa Corsetti, Nicol Trincheri, Lisa Bonello, Lia Mele, Franco Dallavalle, Flavia Salvi, Massimo Pini
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 2, Pp 90-93 (2014)
Hepatosplenic T cell lymphoma (HSTCL) is a type of hematologic neoplasia with a poor prognosis and a high frequency of refractoriness to conventional chemotherapy. The results obtained by high dose chemotherapy followed by autologous stem cells trans
Externí odkaz:
https://doaj.org/article/976124ebae164689b74539a5ed10462c
Autor:
Andrea Gallamini, Sally F. Barrington, Alberto Biggi, Stephane Chauvie, Lale Kostakoglu, Michele Gregianin, Michel Meignan, George N. Mikhaeel, Annika Loft, Jan M. Zaucha, John F. Seymour, Michael S. Hofman, Luigi Rigacci, Alessandro Pulsoni, Morton Coleman, Eldad J. Dann, Livio Trentin, Olivier Casasnovas, Chiara Rusconi, Pauline Brice, Silvia Bolis, Simonetta Viviani, Flavia Salvi, Stefano Luminari, Martin Hutchings
Publikováno v:
Haematologica, Vol 99, Iss 6 (2014)
A retrospective, international, multicenter study was undertaken to assess: (i) the prognostic role of ‘interim’ positron emission tomography performed during treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in patients with Hod
Externí odkaz:
https://doaj.org/article/0e9903afcd5841b2a3d617a8a512f95d
Autor:
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, Vincenzo Pavone, Ileana Baldi, Angelo Michele Carella, Lorella Orsucci, Manuela Zanni, Flavia Salvi, Anna Marina Liberati, Gianluca Gaidano, Chiara Bottelli, Bernardo Rossini, Sonia Perticone, Pasqualina De Masi, Marco Ladetto, Giovannino Ciccone, Antonio Palumbo, Giuseppe Rossi, Umberto Vitolo
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
Despite improvements in standard therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with untreated, diffuse large B-cell lymphoma, up to 40% of these patients relapse. Lenalidomide alone or in combination w
Externí odkaz:
https://doaj.org/article/d397429eab404e86bacf0cbcb89bb67b
Autor:
Francesco Zaja, Stefano De Luca, Umberto Vitolo, Lorella Orsucci, Alessandro Levis, Flavia Salvi, Chiara Rusconi, Erika Ravelli, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano A. Pileri, Elena Sabattini, Stefano Volpetti, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Background Preclinical studies have highlighted the activity of lenalidomide in mantle cell lymphoma and its anti-proliferative synergy with dexamethasone.Design and Methods In this prospective, multicenter, phase II study, patients with relapsed/ref
Externí odkaz:
https://doaj.org/article/833ce7ee81f64cb5baddd32b512672e7
Autor:
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, Giuseppe Rossi, Anna Marina Liberati, Maria Giuseppina Cabras, Barbara Botto, Giovannino Ciccone, Gianluca Gaidano, Lorenzo Falchi, Roberto Freilone, Domenico Novero, Lorella Orsucci, Vincenzo Pavone, Enrico Pogliani, Delia Rota-Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Alessandro Levis
Publikováno v:
Haematologica, Vol 94, Iss 9 (2009)
Background We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.Design and Methods Ninety-four young patie
Externí odkaz:
https://doaj.org/article/e95f5885ff664ac9be3329bb97c79b2a